Real-world evidence-Reference-Cited by-同舟云学术

Real-world evidence

Published:2021-04 Issue:4 Volume:126 Page:385-393.e2
ISSN:1081-1206
Container-title:Annals of Allergy, Asthma & Immunology
language:en
Short-container-title:Annals of Allergy, Asthma & Immunology

Author:

Oppenheimer John,Slade David J.,Hahn Beth A.,Zografos Laurie,Gilsenan Alicia,Richardson David,McSorley David,Lima Robson,Molfino Nestor A.,Averell Carlyne M.

Funder

GlaxoSmithKline

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Immunology and Allergy,Immunology

Reference24 articles.

1. Asthma control and disease burden in patients with asthma and allergic comorbidities;Lee;J Asthma,2018

2. Measuring the cost of poor asthma control and exacerbations;Sullivan;J Asthma,2017

3. Exploring asthma control cutoffs and economic outcomes using the Asthma Control Questionnaire;Sullivan;Ann Allergy Asthma Immunol,2016

4. The relationship between asthma, asthma control and economic outcomes in the United States;Sullivan;J Asthma,2014

5. Uncontrolled asthma in a commercially insured population from 2002 to 2007: trends, predictors, and costs;Sawicki;J Asthma,2010

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Baseline Characteristics and ICS/LAMA/LABA Response in Asthma: Analyses From the CAPTAIN Study;The Journal of Allergy and Clinical Immunology: In Practice;2024-05

2. Burden of illness among patients with asthma prescribed inhaled corticosteroids/long-acting β2-agonists;2023-11-09

3. Clinical inertia in asthma;npj Primary Care Respiratory Medicine;2023-10-14

4. A systematic pharmacology-based in vivo study to reveal the effective mechanism of Yupingfeng in asthma treatment;Phytomedicine;2023-06

5. Suboptimally controlled asthma in patients treated with inhaled ICS/LABA: prevalence, risk factors, and outcomes;npj Primary Care Respiratory Medicine;2023-05-08